Basis of antifibrinolytic therapy
Open Access
- 1 January 1980
- journal article
- therapeutic considerations
- Published by BMJ in Journal of Clinical Pathology
- Vol. 33 (Suppl 14) , 35-40
- https://doi.org/10.1136/jcp.33.suppl_14.35
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Tranexamic Acid in Control of Haemorrhage after Dental Extraction in Haemophilia and Christmas DiseaseBMJ, 1972
- Epsilon‐Aminocaproic Acid Therapy for Dental Extractions in Haemophilia and Christmas Disease: A Double Blind Controlled TrialBritish Journal of Haematology, 1971
- Plasminogen-activator-producing TumourBMJ, 1969
- COMPARATIVE ACTIVITIES OF AMINO ACID AND POLYPEPTIDE INHIBITORS ON NATURAL AND SYNTHETIC SUBSTRATESAnnals of the New York Academy of Sciences, 1968
- In vitro and In vivo Studies with Trasylol, an Anticoagulant and a Fibrinolytic InhibitorBritish Journal of Haematology, 1968
- Clinical Trial of Epsilon-aminocaproic Acid in Severe HaemophiliaBMJ, 1965
- Amino Methyl Cyclohexane Carboxylic Acid (AMCHA), A New Synthetic Fibrinolytic InhibitorBritish Journal of Haematology, 1965
- SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACIDThe Lancet, 1964
- AMINO-METHYL-CYCLOHEXANE-CARBOXYLIC ACID: AMCHAThe Keio Journal of Medicine, 1962
- A SUPPRESSING EFFECT OF ε-AMINO-N-CAPROIC ACID ON THE BLEEDING OF DOGS, PRODUCED WITH THE ACTIVATION OF PLASMIN IN THE CIRCULATORY BLOODThe Keio Journal of Medicine, 1959